Results 351 to 360 of about 22,453,438 (395)
Some of the next articles are maybe not open access.
Interleukin-2 receptor expression and interleukin-2 production in bullous pemphigoid
Archives of Dermatological Research, 1990Expression of interleukin-2 (IL2) receptors was studied on peripheral blood lymphocytes (PBLs) in 25 patients with bullous pemphigoid. Analysis was carried out by flow cytometry. Without immunosuppressive therapy expression of IL2 receptors only on T cells (CD5) was significantly increased as shown by double staining (11.9% +/- 7.8% vs 2.1% +/- 1% in ...
M. Ladusch +3 more
openaire +3 more sources
Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes
Annual Review of Immunology, 1986The development of immunologic approaches to the treatment of cancer has progressed through major changes in the past five years. In the 1970s considerable enthusiasm existed for immunotherapeutic approaches to cancer based on attempts to provide nonspecific stimulation of the host immune system in the hope that this general increase in immune reactivÂ
M T Lotze, S A Rosenberg
openaire +3 more sources
Serum Interleukin-2 and Soluble Interleukin-2 Receptor in Gestrational Trophoblastic Diseases [PDF]
Journal of the Society for Gynecologic Investigation, 1996 To investigate serum interleukin-2 (IL-2) and soluble interleukin-2 receptor (SIL-2) levels in gestational trophoblastic diseases (GTD).Sixty-six patients with GTDs and 23 first-trimester healthy pregnant women (controls) participated in this study.
Nabil A. Darwish +2 more
openaire +3 more sources
Survey of Immunologic Research, 1984
Considerable progress has been made in the past year in clarifying the structure-function relationships that are central in controlling T lymphocyte proliferation. Once a cDNA probe for the IL-2 receptor is cloned, all the primary reagents needed for detailed study of the functional consequences of IL-2 binding will be available and one anticipates ...
openaire +3 more sources
Considerable progress has been made in the past year in clarifying the structure-function relationships that are central in controlling T lymphocyte proliferation. Once a cDNA probe for the IL-2 receptor is cloned, all the primary reagents needed for detailed study of the functional consequences of IL-2 binding will be available and one anticipates ...
openaire +3 more sources
The released interleukin 2 receptor binds interleukin 2 efficiently.
The Journal of Immunology, 1986Abstract The released interleukin 2 receptor (IL 2R) molecule was characterized in order to clarify its biochemical structure and to determine its functional capacity. Enzymatic digestions demonstrated that the released IL 2R, like the cell surface IL 2R, is a complex glycoprotein, modified by the addition of both N- and O-linked ...
L A, Rubin, G, Jay, D L, Nelson
openaire +2 more sources
Annual Review of Immunology, 2008
Much data support an essential role for interleukin (IL)-2 in immune tolerance. This idea is much different from the early paradigm in which IL-2 is central for protective immune responses. This change in thinking occurred when a T regulatory cell defect was shown to be responsible for the lethal autoimmunity associated with IL-2/IL-2R deficiency. This
openaire +2 more sources
Much data support an essential role for interleukin (IL)-2 in immune tolerance. This idea is much different from the early paradigm in which IL-2 is central for protective immune responses. This change in thinking occurred when a T regulatory cell defect was shown to be responsible for the lethal autoimmunity associated with IL-2/IL-2R deficiency. This
openaire +2 more sources
Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.
New England Journal of Medicine, 1987Adoptive immunotherapy involving bolus-dose recombinant interleukin-2 (rIL-2) has been reported to induce tumor regression in some patients with cancer, but has been associated with severe fluid retention and cardiopulmonary stress.
W. West +6 more
semanticscholar +1 more source
Pathology, 1991
Following activation in vitro, peripheral blood mononuclear cells (PBMC) express cell-associated interleukin-2 receptors (IL2R). The present study was undertaken to define the proportion of T lymphocyte subsets that express the IL2R (CD25 antigen) upon different mitogenic stimulation.
Lai, FM, Leung, JCK, Lai, KN
openaire +5 more sources
Following activation in vitro, peripheral blood mononuclear cells (PBMC) express cell-associated interleukin-2 receptors (IL2R). The present study was undertaken to define the proportion of T lymphocyte subsets that express the IL2R (CD25 antigen) upon different mitogenic stimulation.
Lai, FM, Leung, JCK, Lai, KN
openaire +5 more sources
The interleukin-2/interleukin-2 receptor system: structural, immunological, and clinical features
International Journal of Clinical & Laboratory Research, 1992Interleukin-2 (IL-2) has been the first and more extensively studied cytokine, in particular for its central role in the mechanisms of cell growth and differentiation. The function of IL-2 is mediated through specific receptors (IL-2R) present on the membrane of reacting cells.
SEMENZATO, GIANPIETRO CARLO +2 more
openaire +5 more sources
Emerging Drugs, 2000
The development of recombinant interleukin-2 (rIL-2) as a treatment for cancer represented an important milestone in the development of biologic therapies. IL-2 is a natural modulator of the immune system that stimulates specialised immune system cells, namely cytotoxic T-lymphocytes (CTLs) and natural killer cells (NKCs). These cells could potentially
Anagha Gurjal, Philip Agop Philip
openaire +2 more sources
The development of recombinant interleukin-2 (rIL-2) as a treatment for cancer represented an important milestone in the development of biologic therapies. IL-2 is a natural modulator of the immune system that stimulates specialised immune system cells, namely cytotoxic T-lymphocytes (CTLs) and natural killer cells (NKCs). These cells could potentially
Anagha Gurjal, Philip Agop Philip
openaire +2 more sources